| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |